Search Results - "Sherman, K. E."

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV‐HBV Coinfected Transplant Recipients by Coffin, C. S., Stock, P. G., Dove, L. M., Berg, C. L., Nissen, N. N., Curry, M. P., Ragni, M., Regenstein, F. G., Sherman, K. E., Roland, M. E., Terrault, N. A.

“…Liver transplantation (LT) is the treatment of choice for end‐stage liver disease, but is controversial in patients with human immunodeficiency virus (HIV)…”
Get full text

HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? by Blackard, J. T., Sherman, K. E.

“…Because of major advances in the treatment of HIV/AIDS, HIV‐positive persons now live longer, healthier lives; however, hepatitis C virus (HCV) is increasingly…”
Get full text

Hepatitis E infection in HIV-infected liver and kidney transplant candidates by Sherman, K. E., Terrault, N., Barin, B., Rouster, S. D., Shata, M. T.

“…Summary Hepatitis E virus (HEV) has been reported to cause acute and chronic hepatitis in those with HIV infection and among solid organ transplant recipients…”
Get full text

Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro by Martin, C. M., Welge, J. A., Rouster, S. D., Shata, M. T., Sherman, K. E., Blackard, J. T.

“…Occult hepatitis B virus (HBV) infection is characterized by the absence of detectable hepatitis B surface antigen (HBsAg) in the serum, despite detectable HBV…”
Get full text

Gene Expression Profiles in Hepatitis C Virus (HCV) and HIV Coinfection: Class Prediction Analyses before Treatment Predict the Outcome of Anti-HCV Therapy among HIV-Coinfected Persons by Lempicki, R. A., Polis, M. A., Yang, J., McLaughlin, M., Koratich, C., Huang, D. W., Fullmer, B., Wu, L., Rehm, C. A., Masur, H., Lane, H. C., Sherman, K. E., Fauci, A. S., Kottilil, S.

“…Therapy for hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)–infected patients results in modest cure rates. Gene expression patterns in…”
Get full text

Hepatitis C virus treatment and survival in patients with hepatitis C and human immunodeficiency virus co-infection and baseline anaemia by Erqou, S., Mohanty, A., McGinnis, K. A., Vanasse, G., Freiberg, M. S., Sherman, K. E., Butt, A. A.

“…Summary The impact of pretreatment anaemia on survival in individuals with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection is not…”
Get full text

Liver transplant outcomes in HIV(+) haemophilic men by Ragni, M. V., DeVera, M. E., Roland, M. E., Wong, M., Stosor, V., Sherman, K. E., Hardy, D., Blumberg, E., Fung, J., Barin, B., Stablein, D., Stock, P. G.

“…Summary Hepatitis C virus infection is the major cause of end‐stage liver disease and the major indication for transplantation (OLTX), including among HIV‐HCV…”
Get full text

Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay by Shata, M.T., Barrett, A., Shire, N.J., Abdelwahab, S.F., Sobhy, M., Daef, E., El-Kamary, S.S., Hashem, M., Engle, R.E., Purcell, R.H., Emerson, S.U., Strickland, G.T., Sherman, K.E.

“…In developing countries, hepatitis E (HEV) and hepatitis A (HAV) are the major causes of acute viral hepatitis with similar feco-oral modes of transmission. In…”
Get full text

The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long‐term pegylated interferon alfa 2a and ribavirin by Butt, A. A., Umbleja, T., Andersen, J. W., Chung, R. T., Sherman, K. E.

“…Aliment Pharmacol Ther 2011; 33: 1234–1244 Summary Background  The association of anaemia with outcomes in the HCV/HIV coinfected persons undergoing HCV…”
Get full text

Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs by Sherman, K. E., Ke, R., Rouster, S. D., Abdel-Hameed, E. A., Park, C., Palascak, J., Perelson, A. S.

“…Aim Chronic hepatitis C virus (HCV) infection is an important source of morbidity and mortality among haemophiliacs. Limited data are available regarding…”
Get full text

Hepatitis C virus NS3 mutations in haemophiliacs by Lin, M. V., Charlton, A. N., Rouster, S. D., Zamor, P. J., Sherman, K. E.

“…Summary Haemophiliacs have high hepatitis C virus (HCV) exposure risk from blood products that did not undergo heat inactivation or disease‐specific screening…”
Get full text

Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES by Butt, A. A., Ren, Y., Marks, K., Shaikh, O. S., Sherman, K. E.

“…Summary Background Directly acting antiviral agents (DAA) have been associated with hepatic decompensation, especially in patients with pre‐treatment…”
Get full text

Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus-Infected Patients Following Development of Resistance to or Withdrawal of Lamivudine by Bessesen, Mary, Ives, David, Condreay, Lynn, Lawrence, Steven, Sherman, Kenneth E.

“…Lamivudine is a nucleoside analog with activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Patients coinfected with HIV and HBV…”
Get full text

Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals by Martin, C. M., Welge, J. A., Shire, N. J., Rouster, S. D., Shata, M. T., Sherman, K. E., Blackard, J. T.

“…Occult hepatitis B virus (O‐HBV) infection is characterized by the presence of HBV DNA without detectable hepatitis B surface antigen (HBV DNA+/HBsAg−) in the…”
Get full text

T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients by Rashkin, S., Rouster, S., Goodman, Z. D., Sherman, K. E.

“…Limited data suggest that low T‐helper cell levels may be observed in hepatitis C virus (HCV) monoinfected patients with decompensated liver disease. We sought…”
Get full text

Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES by Butt, A. A., Yan, P., Marks, K., Shaikh, O. S., Sherman, K. E.

“…Summary Background Ribavirin is a key component of several hepatitis C virus (HCV) treatment regimens. However, its utility in combination with newer directly…”
Get full text

Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections by Sherman, K E, O'Brien, J, Gutierrez, A G, Harrison, S, Urdea, M, Neuwald, P, Wilber, J

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia by Goedert, J. J., Brown, D. L., Hoots, K., Sherman, K. E.

“…Treatment with contaminated plasma products before 1990 resulted in extraordinary prevalence rates of human immunodeficiency virus (HIV) and hepatitis B and C…”
Get full text

Review article: current status of liver transplantation in HIV‐infected patients by Neff, G. W., Sherman, K. E., Eghtesad, B., Fung, J.

“…Summary The increases in survival of patients infected with human immunodeficiency virus is attributed to the introduction of combination human…”
Get full text

Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings by Butt, A. A., Yan, P., Shaikh, O. S., Freiberg, M. S., Lo Re III, V., Justice, A. C., Sherman, K. E.

“…Summary Effectiveness, safety and tolerability of boceprevir (BOC) and telaprevir (TPV) in actual clinical settings remain unknown. We determined rates of…”
Get full text